These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 37222774)
21. Cancer-associated fibroblasts-derived exosomal METTL3 promotes the proliferation, invasion, stemness and glutaminolysis in non-small cell lung cancer cells by eliciting SLC7A5 m6A modification. Fan Y; Yu Y Hum Cell; 2024 Jul; 37(4):1120-1131. PubMed ID: 38625505 [TBL] [Abstract][Full Text] [Related]
22. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition. Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987 [TBL] [Abstract][Full Text] [Related]
24. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7). Wei K; Gao Y; Wang B; Qu YX Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522 [TBL] [Abstract][Full Text] [Related]
25. METTL3-Mediated N6-Methyladenosine Methylation Modifies Foxp3 mRNA Levels and Affects the Treg Cells Proportion in Peripheral Blood of Patients with Asthma. Fan L; Wu J; Wang H; Chen Q; He X; Wang Q; Yang Z Ann Clin Lab Sci; 2022 Nov; 52(6):884-894. PubMed ID: 36564065 [TBL] [Abstract][Full Text] [Related]
26. M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C. Hou PX; Fan Q; Zhang Q; Liu JJ; Wu Q Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13868. PubMed ID: 38745265 [TBL] [Abstract][Full Text] [Related]
27. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way. Dou X; Wang Z; Lu W; Miao L; Zhao Y BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805 [TBL] [Abstract][Full Text] [Related]
28. Berberine inhibits the progression of breast cancer by regulating METTL3-mediated m6A modification of FGF7 mRNA. Fu W; Liu L; Tong S Thorac Cancer; 2024 Jun; 15(17):1357-1368. PubMed ID: 38709912 [TBL] [Abstract][Full Text] [Related]
29. Sulforaphene suppressed cell proliferation and promoted apoptosis of COV362 cells in endometrioid ovarian cancer. Yu HY; Yang L; Liu YC; Yu AJ PeerJ; 2023; 11():e16308. PubMed ID: 38025760 [TBL] [Abstract][Full Text] [Related]
30. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on Li Q; Yu L; Gao A; Ren R; Zhang J; Cao L; Wang X; Liu Y; Qi W; Cai L; Li W; Wang W; Guo X; Su G; Yu X; Zhang J; Xi B; Zhang Y; Zhang M; Zhang C Arterioscler Thromb Vasc Biol; 2023 May; 43(5):755-773. PubMed ID: 36951060 [TBL] [Abstract][Full Text] [Related]
31. METTL3 in cancer-associated fibroblasts-derived exosomes promotes the proliferation and metastasis and suppresses ferroptosis in colorectal cancer by eliciting ACSL3 m6A modification. Ren H; Wang M; Ma X; An L; Guo Y; Ma H Biol Direct; 2024 Aug; 19(1):68. PubMed ID: 39160584 [TBL] [Abstract][Full Text] [Related]
32. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas. Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359 [TBL] [Abstract][Full Text] [Related]
33. Chinese Ecliptae herba (Eclipta prostrata (L.) L.) extract and its component wedelolactone enhances osteoblastogenesis of bone marrow mesenchymal stem cells via targeting METTL3-mediated m6A RNA methylation. Tian S; Li YL; Wang J; Dong RC; Wei J; Ma Y; Liu YQ J Ethnopharmacol; 2023 Aug; 312():116433. PubMed ID: 37004744 [TBL] [Abstract][Full Text] [Related]
34. METTL3 promotes the progression of osteosarcoma through the N6-methyladenosine modification of MCAM via IGF2BP1. Song D; Wang Q; Yan Z; Su M; Zhang H; Shi L; Fan Y; Zhang Q; Yang H; Zhang D; Liu Q Biol Direct; 2024 Jun; 19(1):44. PubMed ID: 38849910 [TBL] [Abstract][Full Text] [Related]
35. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881 [TBL] [Abstract][Full Text] [Related]
36. METTL3 promotes proliferation and migration of colorectal cancer cells by increasing SNHG1 stability. Xu Y; Bao Y; Qiu G; Ye H; He M; Wei X Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37772373 [TBL] [Abstract][Full Text] [Related]
37. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner. Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135 [TBL] [Abstract][Full Text] [Related]
38. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner. Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101 [TBL] [Abstract][Full Text] [Related]
39. Human aortic smooth muscle cell regulation by METTL3 via upregulation of m6A NOTCH1 modification and inhibition of NOTCH1. Yang J; Fang M; Yu C; Li Z; Wang Q; Li C; Wu J; Fan R Ann Transl Med; 2023 Aug; 11(10):350. PubMed ID: 37675298 [TBL] [Abstract][Full Text] [Related]
40. METTL3 Promotes Osteosarcoma Metastasis via an m6A-dependent Epigenetic Activity of CBX4. Huo XS; Lu D; Chen DG; Ye M; Wang XW; Shang FS Front Biosci (Landmark Ed); 2024 Mar; 29(3):120. PubMed ID: 38538251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]